How AI technology will be applied to the future of healthcare

In the field of artificial intelligence, the United States is in a leading position in talent, research, development and hardware; China has advantages in the application and data level of AI technology. “These two unique advantages make China an excellent ‘experimental field’ for AI technology.”

Combined with the current characteristics and status quo of the development of the medical industry, Zhao Baige further proposed eight coping strategies in order to promote the application of artificial intelligence in the medical and health field. First, establish a high-level coordination mechanism. “China’s current major tasks and work on artificial intelligence have produced some policies that are out of touch and not connected.” In this regard, she believes that it is necessary to solve the problem of the connection between the application of artificial intelligence in various fields and establish a high-level coordination mechanism.

Second, strengthen national policy and financial support for talents in the field of artificial intelligence, intellectual property rights, and scientific research. The medical field focuses on the research and development of basic theories, and is an industry that requires cost input, talent investment and time accumulation. At the same time, attracting talents and occupying intellectual property highlands all over the world requires high cost investment. Third, strengthen the advantages of application scenarios and data usage. Zhao Baige pointed out that China is currently leading in application scenarios and data usage, and should continue to support leading industries.

Fourth, innovate the AI ​​access and charging environment to reduce market access barriers. “Some policy constraints have prevented the rapid commercialization and popularization of China’s medical AI technology, which will inevitably affect the development of research, talent training, and underlying technology development,” she said. Fifth, encourage medical institutions to boldly purchase innovative technologies. Zhao Baige pointed out that at this stage, many medical institutions have used artificial intelligence technology, but the hospital procurement process is often very long, involving many links, and the collection time is long. Encouraging public medical institutions to purchase medical artificial intelligence products that have obtained national certification will greatly contribute to the healthy development and further iteration of the industry.

Sixth, actively encourage and help medical AI companies to go overseas. Zhao Baige believes that China’s medical AI has every opportunity to become a leading innovative technology to help improve the health of people in all countries. “If the country can strongly support Chinese medical AI enterprises to go overseas, and have the confidence to compete fully and fairly with overseas medical AI enterprises, and seize international technical standards, China’s medical AI will have a good chance to become a leading international innovative industry and technology.” AI Technology How will it be applied to the future of healthcare

Seventh, establish a regular communication mechanism between government and enterprises. Zhao Baige said that artificial intelligence companies are developing rapidly, but many companies do not have a deep understanding of the government’s industry development guidance policies, and their thoughts and demands on medical AI applications cannot be quickly reflected to the government, which makes the government unable to quickly obtain market information. In this regard, she suggested establishing a more flexible daily communication and consultation mechanism between government and enterprises to speed up two-way communication.

Eighth, effectively deal with emergencies such as Sino-US trade frictions. Zhao Baige said that many technical advantages of artificial intelligence are still in the hands of the United States, especially after the Sino-US trade friction, the United States has clearly listed AI as an important regulatory field. In this regard, the Chinese government should try its best to maintain applications and data where it already has an advantage, and at the same time encourage Chinese companies and research institutions to catch up with the US through policy and funding guidance. At present, Chinese medical AI companies have gone abroad and have landed in top US hospitals. However, the trade war and US trade protectionism will cast a great shadow on Chinese medical AI going abroad. Secondly, the chips used in Chinese medical AI are also serious. Depends on American chips. These are all risks in China’s medical AI field.